These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9185516)

  • 41. A diurnal rhythm in cerebrospinal fluid corticotrophin-releasing hormone different from the rhythm of pituitary-adrenal activity.
    Kalin NH; Shelton SE; Barksdale CM; Brownfield MS
    Brain Res; 1987 Nov; 426(2):385-91. PubMed ID: 2825918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adrenergic modulation of adrenocorticotropin responses to insulin-induced hypoglycemia and corticotropin-releasing hormone.
    Tomori N; Suda T; Nakagami Y; Tozawa F; Sumitomo T; Ushiyama T; Demura H; Shizume K
    J Clin Endocrinol Metab; 1989 Jan; 68(1):87-93. PubMed ID: 2535853
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hyperkinesia, plasma corticotropin releasing hormone and ACTH in senile dementia.
    Suemaru S; Hashimoto K; Suemaru K; Maeba Y; Matsushita N; Ota Z
    Neuroreport; 1991 Jun; 2(6):337-40. PubMed ID: 1655106
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of the infusion with ACTH or CRH on the secretory activity of rat adrenal cortex.
    Mazzocchi G; Rebuffat P; Meneghelli V; Nussdorfer GG
    J Steroid Biochem; 1989 Jun; 32(6):841-3. PubMed ID: 2547114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity.
    Chan O; Inouye K; Vranic M; Matthews SG
    Endocrinology; 2002 May; 143(5):1761-8. PubMed ID: 11956158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of central corticotropin-releasing hormone in the anorexic and endocrine effects of the bacterial T cell superantigen, Staphylococcal enterotoxin A.
    Kaneta T; Kusnecov AW
    Brain Behav Immun; 2005 Mar; 19(2):138-46. PubMed ID: 15664786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of an interleukin-6- and adrenocorticotropin-dependent, immune-to-adrenal pathway during viral infection.
    Silverman MN; Miller AH; Biron CA; Pearce BD
    Endocrinology; 2004 Aug; 145(8):3580-9. PubMed ID: 15044377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic treatment with the monoamine oxidase inhibitor phenelzine increases hypothalamic-pituitary-adrenocortical activity in male C57BL/6 mice: relevance to atypical depression.
    Kier A; Han J; Jacobson L
    Endocrinology; 2005 Mar; 146(3):1338-47. PubMed ID: 15564336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.
    Kishimoto T; Radulovic J; Radulovic M; Lin CR; Schrick C; Hooshmand F; Hermanson O; Rosenfeld MG; Spiess J
    Nat Genet; 2000 Apr; 24(4):415-9. PubMed ID: 10742109
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human plasma proopiomelanocortin N-terminal peptide and adrenocorticotropin: circadian rhythm, dexamethasone suppression, and corticotropin-releasing hormone stimulation.
    Motomatsu T; Takahashi H; Ibayashi H; Nobunaga M
    J Clin Endocrinol Metab; 1984 Sep; 59(3):495-8. PubMed ID: 6086700
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
    Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
    Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern.
    Avgerinos PC; Schürmeyer TH; Gold PW; Tomai TP; Loriaux DL; Sherins RJ; Cutler GB; Chrousos GP
    J Clin Endocrinol Metab; 1986 May; 62(5):816-21. PubMed ID: 3007554
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats.
    Kamilaris TC; DeBold CR; Johnson EO; Mamalaki E; Listwak SJ; Calogero AE; Kalogeras KT; Gold PW; Orth DN
    Endocrinology; 1991 May; 128(5):2567-76. PubMed ID: 1850357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined corticotropin-releasing hormone and glucocorticoid deficiency does not enhance counterregulatory responses after recurrent hypoglycemia in mice.
    Jacobson L; Pacák K
    Metabolism; 2005 Sep; 54(9):1259-65. PubMed ID: 16125539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
    Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
    Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of L-NAME, a specific nitric oxide synthase inhibitor, on corticotropin-releasing hormone-elicited ACTH and corticosterone secretion.
    Bugajski J; Borycz J; Gadek-Michalska A; Głód R
    J Physiol Pharmacol; 1998 Dec; 49(4):607-16. PubMed ID: 10069701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.
    Cota D; Steiner MA; Marsicano G; Cervino C; Herman JP; Grübler Y; Stalla J; Pasquali R; Lutz B; Stalla GK; Pagotto U
    Endocrinology; 2007 Apr; 148(4):1574-81. PubMed ID: 17194743
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The regulation of adrenocorticotrophic hormone receptor by corticotropin-releasing hormone in human fetal adrenal definitive/transitional zone cells.
    Rehman KS; Sirianni R; Parker CR; Rainey WE; Carr BR
    Reprod Sci; 2007 Sep; 14(6):578-87. PubMed ID: 17959886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Examining the role of endogenous orexins in hypothalamus-pituitary-adrenal axis endocrine function using transient dual orexin receptor antagonism in the rat.
    Steiner MA; Sciarretta C; Brisbare-Roch C; Strasser DS; Studer R; Jenck F
    Psychoneuroendocrinology; 2013 Apr; 38(4):560-71. PubMed ID: 22917622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.